DUBLIN--(BUSINESS WIRE)--The "Global Infusion Pump Software Market Analysis & Trends - Industry Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
The Global Infusion Pump Software Market is poised to grow strong during the forecast period 2017 to 2027.
Some of the prominent trends that the market is witnessing include high growth in emerging countries, rising adoption of specialty infusion systems, and recent technological developments in infusion pump software.
- By the Indication, the market is segmented into the enteral infusion, pain & anesthesia management, general infusion, chemotherapy, insulin infusion, and other indications.
- Based on the Type, the market is fragmented into interoperability software, dose error reduction software (DERS), clinical workflow software, and other types.
- On the basis of the End User, the market is classified into ambulatory care settings, academic & research institutes, hospitals, home care settings, and other end users.
This industry report analyses the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2016, 2017 revenue estimations are presented for 2018 and forecasts from 2019 till 2027.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants, and the future investors.
Report Highlights:
- The report provides a detailed analysis of current and future market trends to identify the investment opportunities
- Market forecasts till 2027, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2027
- Market opportunities and recommendations for new investments
Key Topics Covered:
1 Market Outline
1.1 Research Methodology
1.2 Market Trends
1.3 Regulatory Factors
1.4 End User Analysis
1.5 Strategic Benchmarking
1.6 Opportunity Analysis
2 Executive Summary
3 Market Overview
3.1 Current Trends
3.1.1 High Growth in Emerging Countries
3.1.2 Rising Adoption of Specialty Infusion Systems
3.1.3 Recent Technological Developments in Infusion Pump Software
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
4 Infusion Pump Software Market, By Indication
4.1 Enteral Infusion
4.2 Pain & Anesthesia Management
4.3 General Infusion
4.4 Chemotherapy
4.5 Insulin Infusion
4.6 Other Indications
5 Infusion Pump Software Market, By Type
5.1 Interoperability Software
5.2 Dose Error Reduction Software (DERS)
5.3 Clinical Workflow Software
5.4 Other Types
6 Infusion Pump Software Market, By End User
6.1 Ambulatory Care Settings
6.2 Academic & Research Institutes
6.3 Hospitals
6.4 Home Care Settings
6.5 Other End Users
7 Infusion Pump Software Market, By Geography
7.1 North America
7.1.1 US
7.1.2 Canada
7.1.3 Mexico
7.2 Europe
7.2.1 France
7.2.2 Germany
7.2.3 Italy
7.2.4 Spain
7.2.5 UK
7.2.6 Rest of Europe
7.3 Asia Pacific
7.3.1 China
7.3.2 Japan
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.6 Rest of Asia Pacific
7.4 Middle East
7.4.1 Saudi Arabia
7.4.2 UAE
7.4.3 Rest of Middle East
7.5 Latin America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Rest of Latin America
7.6 Rest of the World (RoW)
7.6.1 South Africa
7.6.2 Others
8 Key Player Activities
8.1 Mergers & Acquisitions
8.2 Partnerships, Joint Ventures, Collaborations and Agreements
8.3 Product Launch & Expansions
8.4 Other Activities
9 Leading Companies
9.1 B. Braun Melsungen AG (B. Braun)
9.2 Baxter International Inc. (Baxter)
9.3 Becton, Dickinson and Company (BD)
9.4 Fresenius Kabi
9.5 ICU Medical Inc. (ICU Medical)
9.6 Medtronic PLC (Medtronic)
9.7 Micrel Medical Devices
9.8 Moog Inc. (Moog)
9.9 Roche Diagnostics (A Division of F. Hoffmann La Roche Ltd.)
9.10 Smiths Medical (A Division of Smiths Group Plc)
9.11 Terumo Corporation
9.12 Ypsomed AG (Ypsomed)
For more information about this report visit https://www.researchandmarkets.com/r/nt447f
